A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan

被引:0
作者
Claudia Petereit
Okan Zaba
Ishak Teber
Heike Lüders
Christian Grohé
机构
[1] Lindenberger Weg 27,ELK Department of Respiratory Diseases
来源
BMC Pulmonary Medicine | / 13卷
关键词
Small cell lung cancer (SCLC); Hyponatremia; Syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 52 条
[1]  
Van Meerbeeck JP(2011)Small-cell lung cancer Lancet 378 1741-55
[2]  
Fennell DA(2011)Small cell lung cancer National Comprehensive Cancer Network. J Natl Compr Canc Netw 10 1086-113
[3]  
De Ruysscher DK(2011)Is hyponatremia a prognostic marker of survival for lung cancer? Pneumologie 65 565-71
[4]  
Kalemkerian GP(2010)The occurrence of hyponatremia in SCLC and the influence on prognosis. A retrospective study of 453 patients treated in a single institution in a 10 year period Lung Cancer 68 111-114
[5]  
Akerley W(2003)Sodium wasting nephropathy caused by cisplatinum in a patient with small cell lung cancer Clin Lung Cancer 5 187-189
[6]  
Bogner P(2012)Diagnosis and management of hyponatremia in cancer patients Oncologist 17 756-65
[7]  
Borghaei H(2006)Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits Am J Med 119 1-8
[8]  
Chow L(1957)A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone Am J Med 23 529-542
[9]  
Downey RJ(1995)Syndrome of inappropriate secretion of anitdiuretic hormone (SIADH) in malignant disease J Inten Med 238 97-110
[10]  
Gandhi L(2011)Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion SALT Investigators. Eur J Endocrinol 164 725-32